Vaccine equity: a case study in investor engagement
07 February 2022
Investors have asked pharma companies in a letter to address COVID vaccine equity. Two signatories, Achmea and Storebrand, reveal the content of their engagement toolbox to hold investee companies to account.
Cookies on Insurance Asset Risk
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here